Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors

Details for Australian Patent Application No. 2009268024 (hide)

Owner Novartis AG

Inventors Briard, Emmanuelle; Rueeger, Heinrich; Veenstra, Siem Jacob; Rondeau, JeanMichel; Tintelnot-Blomley, Marina; Machauer, Rainer; Rogel, Olivier; Moebitz, Henrik; Lueoend, Rainer Martin

Agent Davies Collison Cave

Pub. Number AU-A-2009268024

PCT Pub. Number WO2010/003976

Priority 61/154,573 23.02.09 US; 08160123.9 10.07.08 EP

Filing date 8 July 2009

Wipo publication date 14 January 2010

International Classifications

C07D 335/02 (2006.01) Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/382 (2006.01) - having six-membered rings, e.g. thioxanthenes

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2010/003976 Priority application(s): WO2010/003976

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009268025-Therapeutic use of specific ligand in MSRV associated diseases

2009268022-Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium